Global Industry Analysts, Inc., April 2010, Pages: 221
Generics in India, Breakdown by
Cost (includes corresponding Graph/Chart) II-10
China II-10
China Boosts (H1N1) Influenza A Vaccines Volume II-10
Over 3.7 Million Chinese Immunized Against H1N1 II-10
China Market Report, May 2009, Pages: 30
remained stable generally, thus, the number for livestock’s immunization need is very large.
China’s animal vaccine is broadly divided into two markets; one is the planning immunization products procured
JZMed Inc., Aug 2010, Pages: 299
that approved the H1N1 vaccine. Nowadays most Chinese drug companies that eye on the international markets have their own dedicated drug R&D team. The most popular form of their R&D organization is an internal
Reports from China, Nov 2009, Pages: 102
in the industry
7.1 Major Chinese competitors in the industry
7.2 projects to be constructed in China
8 Foreign market for the disposable vaccine syringe industry
8.1 Introduction
8.2 Major markets in Asia
8
Reports from China, Nov 2009, Pages: 102
in the industry
7.1 Major Chinese competitors in the industry
7.2 projects to be constructed in China
8 Foreign market for the disposable vaccine syringe industry
8.1 Introduction
8.2 Major markets in Asia
8
China Research & Intelligence, Dec 2010, Pages: 70
, immune globulins, and clotting factors.
As the consuming capacity of Chinese consumers and their awareness of protecting health enhancing, Chinese demands for vaccines for human use are growing
Industry Experts, April 2010, Pages: 240
, Interferons, HG Hormones and Other
China
Chart 122: Chinese Biopharmaceuticals Market Analysis (2006-2015) by Product Segment – Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin
Global Industry Analysts, Inc., April 2011, Pages: 402
Table 17: Indian Recent Past, Current & Future Analysis for
Bio-Pharmaceuticals by Segment - Vaccines, Diagnostics,
Therapeutics, and Others Markets Independently Analyzed with
Annual Sales in US
Research In China, Sep 2010, Pages: 121
in the market. Chinesevaccine market has low concentration degree, with many manufacturers. Vaccine I (planned vaccine) still has potentials because of the big difference between China and high-income countries in child
Research In China, Sep 2010, Pages: 121
in the market. Chinesevaccine market has low concentration degree, with many manufacturers. Vaccine I (planned vaccine) still has potentials because of the big difference between China and high-income countries in child
TriMark Publications, May 2010, Pages: 301
. Focusing both on companion (pet) animal markets and agricultural livestock, the report examines the markets for pharmaceuticals, vaccines, diagnostics, and feed additives.
The study reveals:
- the size
Bioplan Associates Inc., March 2008, Pages: 305
strategies, international objectives, partnering strategies, and marketing activities. In addition, subscribers will receive on-going updates to activities and trends in China as the country
Datamonitor, Feb 2011, Pages: 123
driver for drug uptake
Chinese formulary status
Trends in marketing strategies
Marketing strategy for leading brands
Sponsorship/disease awareness campaigns are widely used to promote
Decision Resources, Inc., March 2009, Pages: 49
markets. Meanwhile, the cancer vaccine market is significantly behind the MAb-based market in terms of products on the market, a robust pipeline, and workable technologies, but researchers hold out hope
